The financing follows a period of exceptional growth and market momentum for HealthSnap as healthcare organizations increasingly adopt AI-enabled solutions ...
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta's CDx Accelerator Model...
Patients sought greater transparency over AI-mediated data processing, although more detailed consent controls did not significantly change usability or willingness to share information....
The approach retained most of the performance of centralised training while allowing three health systems to keep patient-level intensive-care data locally....
The proceedings examine clinical validation, patient safety, privacy and accountability as AI tools are integrated into oncology research and care....
The model identified five patient groups with different risks of cardiovascular disease, cognitive decline and death beyond conventional sleep apnoea measures....
AI is increasingly moving beyond routine productivity tasks to influence how MedTech sales teams prioritise opportunities and allocate their time...
The study collected more than 3,250 fresh biopsy specimens across seven medical centers...
Greater access to genomic testing, local population data and real-world evidence will be central to widening the clinical use of liquid biopsy and precision medicine across Asian healthcare systems....
Hospitals need secure deployment platforms, local validation, sustainable financing and clear governance to translate healthcare AI into safe, scalable clinical use....
